IRCCS Istituto Tumori Giovanni Paolo II at ISLB 2026

Nov 7–9, 2026 Madrid, Spain ~700 attendees Website

IRCCS Istituto Tumori Giovanni Paolo II brings 2 presentations to ISLB 2026 in Madrid. Its work centres on measuring circulating tumour DNA in lung, breast and colon cancer. One study combines targeted and shallow whole-genome sequencing to estimate tumour fraction in blood, and another tests plasma DNA profiling around colon cancer surgery.

Organization	ISLB 2026 Attendance
II IRCCS Istituto Tumori Giovanni Paolo II Bari, Italy
Hospitals & cancer centres Public cancer research hospital in Bari.	Poster Part of Poster sessions Integration of Targeted Sequencing and Shallow Whole-genome Sequencing for Tumor Fraction Assessment in Lung and Breast Cancer Liquid Biopsy ctDNA & MRD Collaborators: Regina Elena National Cancer Institute Poster Part of Poster sessions Perioperative Plasma cfDNA Profiling in Colon Cancer: Feasibility and Exploratory Stage-associated ctDNA Analysis ctDNA & MRD

Instantly find 20 buyers from IRCCS Istituto Tumori Giovanni Paolo II

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction